S&P Futures
4,021.00 +19.50 (+0.49%) Dow Futures
32,714.00 +126.00 (+0.39%) Nasdaq Futures
12,788.50 +56.00 (+0.44%) Russell 2000 Futures
1,776.80 +12.00 (+0.68%) Crude Oil
73.68 +0.48 (+0.66%) Gold
1,967.60 -5.90 (-0.30%)
After hours:
Chart Events
Performance Outlook
| Previous Close | 3.3000 |
| Open | 3.3600 |
| Bid | 0.0000 x 1000 |
| Ask | 0.0000 x 1800 |
| Day's Range | 3.2150 - 3.3600 |
| 52 Week Range | 2.0000 - 7.1900 |
| Volume | |
| Avg. Volume | 31,188 |
| Market Cap | 109.065M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GlobeNewswire
Forian Inc. Announces Fourth Quarter and Full Year 2022 Financial Results
Fourth quarter revenue grew 37% year-over-year Forian exits cannabis industry with sale of BioTrack for $30 million NEWTOWN, PA, March 27, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Forian Inc. (Nasdaq: FORA), a provider of data science driven information and analytics solutions to the healthcare and life sciences industries, today announced results for the quarter and year ended December 31, 2022. “I am proud of the team’s fourth quarter results,” said Max Wygod, Forian’s Chairman and Chief Ex
- GlobeNewswire
Forian Inc. to Announce Fourth Quarter and Full Year 2022 Results on March 27, 2023
NEWTOWN, PA, March 14, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Forian Inc. (Nasdaq: FORA), a provider of data science driven information and analytics solutions to the healthcare and life sciences industries, will announce its fourth quarter and full year 2022 financial results on Monday, March 27, 2023, after the close of the market. The Company will host a conference call and webcast at 4:30 p.m. (ET) on March 27, 2023 to discuss the results. To register for the conference call, click here
- GlobeNewswire
Forian Announces the Sale of BioTrack to Alleaves
NEWTOWN, PA and DEERFIELD BEACH, FL, Feb. 13, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Forian Inc. (Nasdaq: FORA), a provider of technology, analytics and data science driven solutions, today announced the sale of Forian’s cannabis software subsidiary, Bio-Tech Medical Software, Inc. (d/b/a BioTrack), to Alleaves, Inc., a provider of ERP software solutions to the cannabis industry, effective February 10, 2023, for a total purchase price of $30 million in cash, comprised of $20 million paid a
